Skip to main content
News > News > In the News: Open Therapeutics’ First Non-Operating Sub (by Tauriga Sciences)

In the News: Open Therapeutics’ First Non-Operating Sub (by Tauriga Sciences)

Tauriga Sciences Inc. Wholly Owned Subsidiary Pilus Energy LLC Executes Commercialization and Distribution Agreement with Singapore Based Naturo Energy Pte. Ltd.

“The Agreement will be exclusive for the continent of Asia and focus on the commercialization of U.S. Patent # 8,354,267 Titled “Microbial Fuel Cell” which was granted to Bacterial Robotics, LLC (“Bacterial Robotics”, presently “Open Therapeutics”) on January 15, 2013.”

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange